Voices Against Brain Cancer Applauds Brain Cancer Research on Drugs That Prevent Glioblastoma Metastasis

Share Article

VABC commends the Mayo Clinic for discovering the use of the drugs Avastin and Dasatinib to prevent tumor metastasis, based on an article on News-Medical.net.

On February 26, Voices Against Brain Cancer (VABC), an advocacy organization dedicated to raising support and awareness for brain cancer research, responds to an article about the Mayo Clinic’s recent discovery that pairing the drugs Avastin and Dasatinib is an effective treatment against glioblastoma multiforme metastasis.

In the News-Medical.net article, Panos Z. Anastasiadis, Ph.D., the Department of Cancer Biology chairman at the Mayo Clinic in Florida, said, “We are very encouraged. This finding could potentially benefit many cancer patients.” According to the article, the drug bevacizumab (Avastin) temporarily shrinks the cancer and then the cancer returns and metastasizes; however, paired with the Dastinib, a drug for blood cancer treatment, the drugs stop the brain cancer from spreading.

The Mayo Clinic outlined its study in the online version of PLOS ONE and is currently conducting a “randomized phase II study of 100 patients through Alliance for Clinical Trials in Oncology.” The article stated, “Researches will work to identify which patients benefit the most from this new treatment, which do not, and why.”

Michael Klipper, VABC chairman, finds the study encouraging for brain cancer patients and says, “We’re grateful that researchers have found an effective treatment for glioblastoma, the deadliest and most common form of brain cancer. The research community has been turning up some fantastic discoveries for glioblastoma treatments in the last year, especially, and we’re looking forward to a promising future for brain cancer patients.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Alicia McAllister
Visit website